PRESS RELEASE published on 04/02/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Nomination d’Amit Munshi en tant que Président du Conseil d’Administration chez Sensorion, société de biotechnologie spécialisée dans les thérapies auditives. Annonce du départ de M. Furey Biotechnologie Conseil D'administration Sensorion Thérapies Auditives Amit Munshi
BRIEF published on 03/26/2025 at 07:35, 1 year 5 months ago Sensorion rejoint la conférence Van Lanschot Kempen à Amsterdam Biotechnologie Investisseurs Conference Sensorion Perte Auditive
BRIEF published on 03/26/2025 at 07:35, 1 year 5 months ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence Van Lanschot Kempen dédiée aux sciences de la vie à Amsterdam. La société présente ses thérapies innovantes pour la perte auditive Biotechnologie Conference Sciences De La Vie Sensorion Thérapies Auditives
PRESS RELEASE published on 03/26/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 1 year 6 months ago Sensorion : Bilan 2024 et Perspectives pour 2025 Résultats Financiers Investissements Thérapies Géniques SENS-401 SENS-501
BRIEF published on 03/14/2025 at 07:35, 1 year 6 months ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats financiers pour l’exercice 2024, fait le point sur ses activités et annonce la mise à disposition du rapport annuel. Renforcement financier, essais cliniques avancés Résultats Financiers Innovation Scientifique Thérapie Génique Études Cliniques Sensorion
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 6 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 1 year 6 months ago Sensorion conclut le recrutement pour l'essai NOTOXIS sur le SENS-401 Essai Clinique Sensorion SENS-401 Cisplatine Ototoxicité
Published on 09/18/2026 at 00:55, 1 hour 41 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 2 hours 11 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 4 hours 21 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 4 hours 21 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 4 hours 31 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 7 hours 35 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 7 hours 37 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 8 hours 10 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 8 hours 25 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 8 hours 49 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 8 hours 56 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/17/2026 at 17:40, 8 hours 56 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
